KR

Krupa Rajen Gandhi

Active Director Director DIN 00294629
DIN 00294629 First appointment Mar 1997 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Mar 1997
Shareholding value •••• Premium profile

About Krupa Rajen Gandhi

Data last updated:

Krupa Rajen Gandhi is a Director at Century Enka Limited (since 2020) and Director at Kruti Finance And Holdings Pvt Ltd (since 1997). The companies operate in Manufacturing, Financial Services and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹2,039 Cr; the largest is Century Enka Limited at ₹2,039 Cr (FY 2025). Earlier, Krupa Rajen Gandhi was a Director at J B Chemicals And Pharmaceuticals Limited (2014–2020).

DIN 00294629
Primary Designation Director
Industry Manufacturing
First Appointment 26 Mar 1997
Oldest Company Age 60 yrs
Largest company Century Enka Limited · ₹2,039 Cr (FY 2025)
Combined revenue ₹2,039 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Century Enka Limited L24304PN1965PLC139075
Director14 Aug 20201965₹2,039 Cr (FY 2025)Active
Kruti Finance And Holdings Pvt Ltd U67120MH1985PTC036880
Director26 Mar 19971985₹5 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jan 20141976₹4,208 Cr (FY 2026)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Krupa Rajen Gandhi

NameDINCompanyDesignation
Ashish Razdan03584734Century Enka LimitedDirector
Jayant Vasant Dhobley02402556Century Enka LimitedDirector
Rahul DubeyCentury Enka LimitedCompany Secretary
Rajashree Birla00022995Century Enka LimitedDirector
Ravindra Kastia00528025Century Enka LimitedDirector
Suresh Sodani08789604Century Enka LimitedManaging Director
Suresh SodaniCentury Enka LimitedCeo
Yogesh Raghunath ShahCentury Enka LimitedCfo
Hasyalata Bansidhar Mehta00294684Kruti Finance And Holdings Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Century Enka Limited
Kruti Finance And Holdings Pvt Ltd
J B Chemicals And Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Krupa Rajen Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krupa Rajen Gandhi

Krupa Rajen Gandhi currently holds 2 directorships: Century Enka Limited (Director, since 14 Aug 2020, revenue ₹2,039 Cr (FY 2025)); Kruti Finance And Holdings Pvt Ltd (Director, since 26 Mar 1997, revenue ₹5 Lakh (FY 2024)).

Krupa Rajen Gandhi was first appointed on 26 Mar 1997 as Director at Kruti Finance And Holdings Pvt Ltd. The most recent appointment on record is 14 Aug 2020 at Century Enka Limited.

The 2 current companies of Krupa Rajen Gandhi that report revenue have a combined latest revenue of ₹2,039 Cr: Century Enka Limited ₹2,039 Cr (FY 2025); Kruti Finance And Holdings Pvt Ltd ₹5 Lakh (FY 2024).

Krupa Rajen Gandhi held 1 earlier board appointment: J B Chemicals And Pharmaceuticals Limited (Director, 15 Jan 2014 to 31 Aug 2020).

The current boards of Krupa Rajen Gandhi's companies include Ashish Razdan (Century Enka Limited), Jayant Vasant Dhobley (Century Enka Limited), Rahul Dubey (Century Enka Limited), Rajashree Birla (Century Enka Limited), Ravindra Kastia (Century Enka Limited), Suresh Sodani (Century Enka Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available